Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs
Authors
Keywords
-
Journal
JOURNAL OF PHYSIOLOGY-LONDON
Volume 594, Issue 20, Pages 5959-5974
Publisher
Wiley
Online
2016-06-08
DOI
10.1113/jp272512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases
- (2016) Jenny Y.Y. Ooi et al. RNA Biology
- Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
- (2016) Bianca C. Bernardo et al. Scientific Reports
- Deep sequencing of small RNA facilitates tissue and sex associated microRNA discovery in zebrafish
- (2015) Candida Vaz et al. BMC GENOMICS
- MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial InfarctionNovelty and Significance
- (2015) Yanfei Yang et al. CIRCULATION RESEARCH
- Gender-specific medicine in the genomic era
- (2015) M. J. Legato CLINICAL SCIENCE
- miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart
- (2015) Bianca C Bernardo et al. Future Medicinal Chemistry
- miR-34: from bench to bedside
- (2015) Massimiliano Agostini et al. Oncotarget
- Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy
- (2014) Bianca C. Bernardo et al. FASEB JOURNAL
- The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy
- (2014) Jenny YY Ooi et al. Future Medicinal Chemistry
- Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
- (2014) Bianca C. Bernardo et al. PLoS One
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
- (2014) Geeta Sapra et al. Nature Communications
- Influence of sex differences on microRNA gene regulation in disease
- (2014) Salil Sharma et al. Biology of Sex Differences
- Circulating p53-Responsive MicroRNAs Are Predictive Indicators of Heart Failure After Acute Myocardial Infarction
- (2013) Sen Matsumoto et al. CIRCULATION RESEARCH
- Regulation of Cardiac MicroRNAs by Cardiac MicroRNAs
- (2013) Scot J. Matkovich et al. CIRCULATION RESEARCH
- Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart
- (2013) Ana Maria Queirós et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- MicroRNA-34a regulates cardiac ageing and function
- (2013) Reinier A. Boon et al. NATURE
- Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2
- (2013) Yasuhiro Maejima et al. NATURE MEDICINE
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1
- (2013) Alicia M. Evangelista et al. PHYSIOLOGICAL GENOMICS
- A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction
- (2013) Yvan Devaux et al. PLoS One
- Functions of MicroRNAs in Cardiovascular Biology and Disease
- (2012) Akiko Hata Annual Review of Physiology
- MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression
- (2012) Tsuyoshi Tabuchi et al. CLINICAL SCIENCE
- Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
- (2012) B. C. Bernardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Introduction to Murine Models of Atrial Fibrillation
- (2012) Genna Riley et al. Frontiers in Physiology
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- A MicroRNA Guide for Clinicians and Basic Scientists: Background and Experimental Techniques
- (2011) Bianca C. Bernardo et al. Heart Lung and Circulation
- Sex Differences in Cardiomyocyte Connexin43 Expression
- (2011) Brian L Stauffer et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Silencing of microRNA families by seed-targeting tiny LNAs
- (2011) Susanna Obad et al. NATURE GENETICS
- Putting gender on the agenda
- (2010) NATURE
- Sex bias in trials and treatment must end
- (2010) Alison M. Kim et al. NATURE
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
- (2009) Lynette Pretorius et al. AMERICAN JOURNAL OF PATHOLOGY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now